CHMP positive for Welireg (belzutifan) to treat von Hippel-Lindau disease and renal cell carcinoma – Merck Inc
Merck Inc., ( known as MSD outside of the United States and Canada), announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted… read more.
